Invasive lobular cancer (ILC) tends to be significantly larger in size with significantly more positive lymph nodes, whereas ILC has a significantly more favorable outcome, compared to stage-matched invasive ductal carcinoma (IDC). The mechanism accounting for such differences remains elusive. Based on morphological, immunohistochemical, and molecular studies of over 1,000 cases of human breast cancers, we hypothesize that the differences may result from the structural and/or functional differences of their surrounding myoepithelial cell layers, which dictate lobular and ductal tumor cells to follow different pathways of invasion or metastasis. The background, rationale, supportive data, and implications of our hypothesis are presented and ...
Invasive lobular breast cancer (ILC) is less common than invasive ductal breast cancer (IDC) and app...
Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer, an...
Invasive lobular breast cancer (ILC) is the second most common histological subtype of breast cancer...
The human breast lobular and ductal structures and the derived tumors from these structures differ s...
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer (BC):...
International audienceInvasive ductal carcinomas (IDCs) and invasive lobular carcinomas (ILCs) are t...
Mammary myoepithelial cells have been the foster child of breast cancer biology and have been largel...
The aim of this study was to determine whether the metastatic potential of breast cancer could be re...
Invasive lobular carcinoma (ILC) accounts for 8-14% of all breast cancers and carries distinct progn...
Background: ILC is less common than IDC and is usually diagnosed at a later stage Purpose:The aim of...
SummaryThe transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a poorly understoo...
The transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a key event in breast tum...
Objective To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ...
Myoepithelial cells (MECs) constitute a continuous layer of cells surrounding the breast glands, loc...
Invasive lobular breast cancer (ILC) is less common than invasive ductal breast cancer (IDC) and app...
Invasive lobular breast cancer (ILC) is less common than invasive ductal breast cancer (IDC) and app...
Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer, an...
Invasive lobular breast cancer (ILC) is the second most common histological subtype of breast cancer...
The human breast lobular and ductal structures and the derived tumors from these structures differ s...
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer (BC):...
International audienceInvasive ductal carcinomas (IDCs) and invasive lobular carcinomas (ILCs) are t...
Mammary myoepithelial cells have been the foster child of breast cancer biology and have been largel...
The aim of this study was to determine whether the metastatic potential of breast cancer could be re...
Invasive lobular carcinoma (ILC) accounts for 8-14% of all breast cancers and carries distinct progn...
Background: ILC is less common than IDC and is usually diagnosed at a later stage Purpose:The aim of...
SummaryThe transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a poorly understoo...
The transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a key event in breast tum...
Objective To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ...
Myoepithelial cells (MECs) constitute a continuous layer of cells surrounding the breast glands, loc...
Invasive lobular breast cancer (ILC) is less common than invasive ductal breast cancer (IDC) and app...
Invasive lobular breast cancer (ILC) is less common than invasive ductal breast cancer (IDC) and app...
Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer, an...
Invasive lobular breast cancer (ILC) is the second most common histological subtype of breast cancer...